Bob Roshanravan
broshanr.bsky.social
Bob Roshanravan
@broshanr.bsky.social
Paul F. Gulyassy Endowed Professor, UCD Div of Nephrology, Affiliate Investigator - Kidney Research Institute, Deputy Editor CJASN, views expressed are my own.
Reposted by Bob Roshanravan
Transportation insecurity negatively impacts people with end stage kidney disease (ESKD) who receive in-center dialysis, leading to missed treatments and higher mortality rates among adults without private transportation. kidney.pub/CJASN0753
#ASNCJASN
@broshanr.bsky.social
June 23, 2025 at 7:30 PM
Reposted by Bob Roshanravan
Compared to WB, PRBC perfusion is superior in mitigating post-ischemia damage and facilitating function and metabolic recovery of high-risk kidneys subjected to long CITs during a three-hour EVNP. https://bit.ly/KID0815
#ASNKidney360
@arahmadi.bsky.social
@broshanr.bsky.social
May 16, 2025 at 7:00 PM
Reposted by Bob Roshanravan
Kidney disease patients experience muscle abnormalities, affecting their physical performance and leading to increased morbidity and mortality. Research on Intermuscular Adipose Tissue (IMAT) could improve function and reduce adverse outcomes. bit.ly/CJASN0745
@broshanr.bsky.social
#ASNCJASN
May 14, 2025 at 5:00 PM
Impaired Incretin Homeostasis in Nondiabetic... : Clinical Journal of the American Society of Nephrology journals.lww.com/cjasn/fullte...
Impaired Incretin Homeostasis in Nondiabetic... : Clinical Journal of the American Society of Nephrology
with insulin response and coincided with persistently greater glucagon levels to oral glucose tolerance testing in CKD.Disruption in the incretin system and glucagon dynamics may contribute to metabol...
journals.lww.com
November 26, 2024 at 10:05 PM